Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NPO Petrovax Pharm LLC

www.petrovax.ru

Latest From NPO Petrovax Pharm LLC

Priming Russia’s Pharma Industry For Innovation

The Russian government’s aggressive plan to modernize the country’s pharmaceutical industry is stimulating entrepreneurial activities, as well as a flurry of deal activity between local and foreign companies. Many uncertainties remain about the potential opportunities, however, as foreign companies try to sort out changing regulatory and business dynamics.

BioPharmaceutical Strategy

Abbott To Buy Russia's Petrovax In Deal Worth As Much As $500 Million

Abbott Laboratories plans to acquire Russia's Petrovax Pharm for as much as $500 million for access to the nation's 12th largest drug maker, a specialist in vaccines.

BioPharmaceutical Deals

Emerging Markets Earnings Roundup: Roche, Johnson & Johnson, Abbott (Part 1)

Emerging markets were a mixed picture for Big Pharma in the third quarter, with China the clear leader, but overall key markets continued to see slower growth, which many blamed on the slowdown in the West.

BioPharmaceutical Medical Device

Abbott Said To Acquire First U.S. Production Facility In Russia

Abbott Laboratories reportedly plans to buy a Russian production facility in a deal that could rank as the nation's third largest pharmaceutical acquisition.

BioPharmaceutical Manufacturing
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Immune Disorders
  • Infectious & Viral Diseases
  • Alias(es)
  • Petrovax Pharm
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Eastern Europe
        • Russia
  • Parent & Subsidiaries
  • NPO Petrovax Pharm LLC
  • Senior Management
  • Andrey Kalashnikov, Strategic Dev. Dir.
    Oleg Rukevich, Sales & Mktg. Dir.
    Arkady Nekrasov, General Dir.
  • Contact Info
  • NPO Petrovax Pharm LLC
    Phone: (7) 495 984 27 53
    2 Dnepropetrovskaya St, 4th Fl.
    Ste. B 4/4
    Moscow, 115598
    Russia
Advertisement
Advertisement
UsernamePublicRestriction

Register